世界のHER2 (ヒト上皮成長因子受容体 2) 阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4306
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、HER2 (ヒト上皮成長因子受容体 2) 阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（乳がん、胃がん、卵巣がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤の市場動向
・企業の競争状況、市場シェア
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤の種類別市場規模と予測2016-2027（単剤療法、併用療法）
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤の用途別市場規模と予測2016-2027（乳がん、胃がん、卵巣がん、その他）
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・HER2 (ヒト上皮成長因子受容体 2) 阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（F. Hoffmann-La Roche Ltd、Merck & Co., Inc、Novartis AG、Pfizer Inc、Puma Biotechnology, Inc）
・結論

HER2 regulates cell growth, survival and differentiation through a variety of signal transduction pathways.Several cancers, including breast, stomach and ovarian, are on the rise because of overexpression of HER2, which is inhibited by HER2 inhibitors

Market Analysis and Insights: Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market
The global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market.

Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Scope and Market Size
HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Combination Therapy

Segment by Application
Breast Cancer
Gastric Cancer
Ovarian Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
F. Hoffmann-La Roche Ltd
Merck & Co., Inc
Novartis AG
Pfizer Inc
Puma Biotechnology, Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Gastric Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Perspective (2016-2027)
2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Growth Trends by Regions
2.2.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Industry Dynamic
2.3.1 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends
2.3.2 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers
2.3.3 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges
2.3.4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue
3.1.1 Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Revenue (2016-2021)
3.1.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue
3.4 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio
3.4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2020
3.5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Key Players Head office and Area Served
3.6 Key Players HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Solution and Service
3.7 Date of Enter into HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Type
4.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2022-2027)

5 HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Breakdown Data by Application
5.1 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027)
6.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
6.2.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021)
6.2.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027)
6.2.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027)
6.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
6.3.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021)
6.3.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027)
6.3.3 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027)
6.4 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country
6.4.1 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021)
6.4.2 North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027)
7.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
7.2.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027)
7.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
7.3.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027)
7.4 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country
7.4.1 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
8.2.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
8.3.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region
8.4.1 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027)
9.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
9.2.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027)
9.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
9.3.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027)
9.4 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country
9.4.1 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type
10.2.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application
10.3.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country
10.4.1 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd
11.1.1 F. Hoffmann-La Roche Ltd Company Details
11.1.2 F. Hoffmann-La Roche Ltd Business Overview
11.1.3 F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.1.4 F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd Recent Development
11.2 Merck & Co., Inc
11.2.1 Merck & Co., Inc Company Details
11.2.2 Merck & Co., Inc Business Overview
11.2.3 Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.2.4 Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
11.2.5 Merck & Co., Inc Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.3.4 Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Details
11.4.2 Pfizer Inc Business Overview
11.4.3 Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.4.4 Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
11.4.5 Pfizer Inc Recent Development
11.5 Puma Biotechnology, Inc
11.5.1 Puma Biotechnology, Inc Company Details
11.5.2 Puma Biotechnology, Inc Business Overview
11.5.3 Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Introduction
11.5.4 Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
11.5.5 Puma Biotechnology, Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions (2016-2021)
Table 8. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions (2022-2027)
Table 10. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Trends
Table 11. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Drivers
Table 12. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Challenges
Table 13. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Restraints
Table 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players (2016-2021)
Table 16. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2020)
Table 17. Ranking of Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product Solution and Service
Table 21. Date of Enter into HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 24. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2016-2021)
Table 25. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2016-2021)
Table 29. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 34. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann-La Roche Ltd Company Details
Table 62. F. Hoffmann-La Roche Ltd Business Overview
Table 63. F. Hoffmann-La Roche Ltd HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 64. F. Hoffmann-La Roche Ltd Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann-La Roche Ltd Recent Development
Table 66. Merck & Co., Inc Company Details
Table 67. Merck & Co., Inc Business Overview
Table 68. Merck & Co., Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 69. Merck & Co., Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million)
Table 70. Merck & Co., Inc Recent Development
Table 71. Novartis AG Company Details
Table 72. Novartis AG Business Overview
Table 73. Novartis AG HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 74. Novartis AG Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million)
Table 75. Novartis AG Recent Development
Table 76. Pfizer Inc Company Details
Table 77. Pfizer Inc Business Overview
Table 78. Pfizer Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 79. Pfizer Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million)
Table 80. Pfizer Inc Recent Development
Table 81. Puma Biotechnology, Inc Company Details
Table 82. Puma Biotechnology, Inc Business Overview
Table 83. Puma Biotechnology, Inc HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Product
Table 84. Puma Biotechnology, Inc Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021) & (US$ Million)
Table 85. Puma Biotechnology, Inc Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application: 2020 VS 2027
Figure 5. Breast Cancer Case Studies
Figure 6. Gastric Cancer Case Studies
Figure 7. Ovarian Cancer Case Studies
Figure 8. Others Case Studies
Figure 9. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Report Years Considered
Figure 10. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions: 2020 VS 2027
Figure 13. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Regions (2022-2027)
Figure 14. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Players in 2020
Figure 15. Global Top HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors as of 2020
Figure 16. The Top 10 and 5 Players Market Share by HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue in 2020
Figure 17. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2016-2021)
Figure 18. Global HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Revenue Market Share by Type (2022-2027)
Figure 19. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027)
Figure 21. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027)
Figure 22. North America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027)
Figure 23. United States HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027)
Figure 27. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027)
Figure 28. Europe HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027)
Figure 29. Germany HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027)
Figure 37. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027)
Figure 38. Asia-Pacific HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Region (2016-2027)
Figure 39. China HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027)
Figure 47. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027)
Figure 48. Latin America HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027)
Figure 49. Mexico HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Type (2016-2027)
Figure 53. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Application (2016-2027)
Figure 54. Middle East & Africa HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Share by Country (2016-2027)
Figure 55. Turkey HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
Figure 59. Merck & Co., Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
Figure 61. Pfizer Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
Figure 62. Puma Biotechnology, Inc Revenue Growth Rate in HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5726 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北...

世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年）

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-6061 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血管内皮増殖因子（VEGF）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別市場規模（腫瘍、眼科）、主要地...

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年）

Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5815 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要...

世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5949 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その...

世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場規模・現状・予測（2021年-2027年）

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5932 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オラパリブ、タラゾパリブ）、用途別市場規模（卵巣がん、乳がん、その他）、主要地域別市場規模（北米、アメリ...

世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年）

Global NT 3 Growth Factor Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5898 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、NT3成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AZD-7451、ラロトレクチニブ、DS-6051、LM-22B10、その他）、用途別市場規模（乳がん、脳がん、固形がん、結腸がん、...

上皮成長因子（EGF）のグローバル市場2021

Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Sales Market Report 2021
QAF27671 2021年4月13日 131Pages
本市場調査資料では、世界の上皮成長因子（EGF）市場について種類別（液体、粉末）、用途別（EGFクリーム、EGFローション、EGFマスク、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価...

世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場規模・現状・予測（2021年-2027年）

Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market Size, Status and Forecast 2021-2027
QFJ1-6055 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、腫瘍壊死因子受容体スーパーファミリーメンバー9の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Ultra-41BBL、PRS-342、ISAS-01、EU-101、その他）、用途別市場規模（胃がん、膀...

世界の高親和性神経成長因子受容体市場規模・現状・予測（2021年-2027年）

Global High Affinity Nerve Growth Factor Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5780 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、高親和性神経成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ASP-7962、AZD-7451、BNN-27、Cenegermin、CRB-0089、その他）、用途別市場規模（胆管がん、...

世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年） The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. The high efficacy of EGFR inhibitors in the treatment of various types of cancer indicati…
世界の胃がん治療市場規模・現状・予測（2021年-2027年） Stomach cancer is the fifth most common cancer in the world Market Analysis and Insights: Global Stomach Cancer and Gastric Cancer Treatment Market The global Stomach Cancer and Gastric Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR …
世界のNT3成長因子受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global NT 3 Growth Factor Receptor Market The global NT 3 Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
上皮成長因子（EGF）のグローバル市場2021 Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation…
世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market The global Tumor Necrosis Factor Receptor Superfamily Member 9 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…